The impact of Aryl hydrocarbon receptor signaling on Toll like receptor-mediated inflammation
芳基碳氢化合物受体信号传导对 Toll 样受体介导的炎症的影响
基本信息
- 批准号:10569113
- 负责人:
- 金额:$ 33.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-09 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAntigen-Presenting CellsAryl Hydrocarbon ReceptorAsthmaAutoimmune DiseasesAutoimmunityB-LymphocytesBindingBinding SitesBiologicalBone MarrowCell physiologyCellsChronic DiseaseCommunicable DiseasesCommunicationDNA BindingDataDendritic CellsDevelopmentDioxinsElementsEnvironmental PollutantsEnvironmental Risk FactorEventExposure toFutureGene ExpressionGene Expression ProfilingGenesGeneticGenomeGoalsHealthHumanHypersensitivityIL12A geneImmuneImmune System DiseasesImmune responseImmune systemImmunityImmunoglobulin FragmentsImmunologic Deficiency SyndromesImmunologic MonitoringImmunomodulatorsImmunosuppressionInfectionInflammationInflammatoryInflammatory ResponseInterleukin-1 betaInterleukin-6Knockout MiceLeadLigandsLinkLocationLogicLymphocyteMacrophageMapsMediatingMethodsModelingMolecularMonitorMusNF-kappa BOutcomePathologicPathway interactionsPhysiologicalPlayPositron-Emission TomographyProcessProteinsREL ProteinRadioimmunoconjugateReceptor ActivationReceptor SignalingRegulationRegulatory T-LymphocyteReportingRepressor ProteinsRoleSchemeShockSignal PathwaySignal TransductionStimulusSurface AntigensT cell differentiationT-Cell ActivationT-LymphocyteTestingTimeTissuesToll-like receptorsToxic Environmental SubstancesToxic effectTranscription RepressorTransgenic MiceWorkaryl hydrocarbon receptor ligandcell typechromatin immunoprecipitationchronic inflammatory diseasecytokinegenome-wide analysisimmune activationimmune system functionimmunoreactionimmunoregulationimmunotoxicityin vivoinnovationinsightmolecular targeted therapiesmonocytemouse modelmutantneutrophilnoveloverexpressionpathogenprotein protein interactionreceptorrecruitresponsesensor
项目摘要
Project Summary/Abstract
The aryl hydrocarbon receptor (AhR) plays an important role in regulating immune responses and exposure to
AhR-activating compounds, including environmental toxicants such as dioxins may contribute to the
dysregulation of cytokines and the development of immune system disorders. The ligand-dependent activation
of AhR can promote differentiation of inflammatory T helper Th17 cells or lead to profound immunosuppression
and an increase of regulatory T cells. Significant gaps exist in our understanding of how the AhR regulates the
inter- and intracellular communication processes between dendritic cells (DC) and other immune cells on the
molecular level, which is of central importance to understanding both physiologic and pathophysiologic immune
reactions mediated through AhR. The overall goal of this proposal is to identify the functional role of the AhR and
its specific repressor (AhRR) interacting with Toll-like receptor (TLR) and NFkB signaling in controlling function
and differentiation of DC and T-cell activation. The reported dysregulation of TLR and NFkB signaling by AhR
ligands may be key steps in triggering immune system disorders. The transcriptional repressor of the AhR, the
AhRR is implemented in the AhR pathway, although much remains to be elucidated at the level of TLR and
NFkB signaling. In transgenic mice overexpressing AhRR we discovered that AhRR is critically involved in
regulation of dioxin-induced inflammatory gene expression as well as LPS-mediated inflammatory responses
and LPS shock. Thus, the AhRR Tg mice give us the opportunity to recognize how AhRR is involved in the
regulation of TLR-mediated responses and other parts of the immune system. Bone-marrow derived DC from
genetic mouse models as well as human DC, will be used to investigate how DC are regulated through ligand-
induced activation of the AhR and inflammatory signals via TLR/NFkB. A genome-wide identification of AhR/Rel
binding sites will be conducted and related to gene expression analysis. Mutants of binding sites will be
generated to validate whether a particular binding event is actually required to regulate the expression of target
genes. Protein-protein interaction studies will identify the specific interacting domains of AhR and Rel proteins
and provide insight into how these interactions impact the functional activity of each protein and the outcome of
AhR/NFkB crosstalk. A novel in vivo method to monitor immune responses noninvasively via Positron Emission
Tomography (immuno-PET) imaging will be used to ultimately show how AhR ligands modify TLR-mediated
recruitment and accumulation of DC, neutrophils, B cells, and T cells in vivo. This study can provide a definite
link and mechanism between the exposure to AhR activating compounds and the development of inflammatory
chronic diseases. Findings will allow for more clearly defined endpoints to assess the effects and toxicity of AhR
activating ligands including environmental pollutants. This study will also provide new concepts for future
innovative uses of AhR and AhRR as molecular targets for therapeutic applications in inflammation, infection,
and chronic diseases.
项目摘要/摘要
芳基烃受体(AHR)在调节免疫反应和暴露中起着重要作用
AHR激活化合物,包括环境有毒物质,例如二恶英可能有助于
细胞因子的失调和免疫系统疾病的发展。配体依赖性激活
AHR可以促进炎症T助手Th17细胞的分化或导致深刻的免疫抑制
并增加调节T细胞。我们对AHR如何调节的理解存在很大的差距
树突状细胞(DC)和其他免疫细胞之间的细胞间和细胞内通信过程
分子水平,这对于理解生理和病理生理免疫至关重要
通过AHR介导的反应。该提案的总体目标是确定AHR的功能作用
它在控制功能中与Toll样受体(TLR)和NFKB信号相互作用的特定阻遏物(AHRR)
DC和T细胞激活的分化。据报道,AHR的TLR和NFKB信号失调
配体可能是触发免疫系统疾病的关键步骤。 AHR的转录阻遏物,
AHRR在AHR途径中实施,尽管在TLR的水平和
NFKB信号。在过表达AHRR的转基因小鼠中,我们发现AHRR与
调节二恶英诱导的炎症基因表达以及LPS介导的炎症反应
和LPS Shock。因此,AHRR TG小鼠使我们有机会认识AHRR如何参与
TLR介导的反应和免疫系统其他部分的调节。骨头arrow从
遗传小鼠模型以及人类DC将用于研究如何通过配体调节DC
通过TLR/NFKB诱导AHR激活和炎症信号。全基因组识别AHR/REL的鉴定
结合位点将进行并与基因表达分析有关。结合位点的突变体将是
生成以验证是否实际需要特定的结合事件来调节目标的表达
基因。蛋白质 - 蛋白质相互作用研究将确定AHR和REL蛋白的特定相互作用结构域
并提供有关这些相互作用如何影响每种蛋白质的功能活性和结果的见解
AHR/NFKB串扰。一种新型的体内方法,可通过正电子发射来监测免疫反应
层析成像(免疫-ET-PET)成像将最终显示AHR配体如何修改TLR介导
DC,中性粒细胞,B细胞和T细胞的募集和积累。这项研究可以提供明确的
暴露于AHR激活化合物与炎症的发展之间的联系和机制
慢性疾病。调查结果将允许更明确的终点来评估AHR的影响和毒性
激活配体在内,包括环境污染物。这项研究还将为未来提供新的概念
AHR和AHRR作为炎症,感染,
和慢性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPH F A VOGEL其他文献
CHRISTOPH F A VOGEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPH F A VOGEL', 18)}}的其他基金
The impact of Aryl hydrocarbon receptor signaling on Toll like receptor-mediated inflammation
芳基碳氢化合物受体信号传导对 Toll 样受体介导的炎症的影响
- 批准号:
10367788 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
Air pollution, atherosclerosis, and the role of the aryl hydrocarbon receptor
空气污染、动脉粥样硬化和芳烃受体的作用
- 批准号:
10316177 - 财政年份:2019
- 资助金额:
$ 33.87万 - 项目类别:
Air pollution, atherosclerosis, and the role of the aryl hydrocarbon receptor
空气污染、动脉粥样硬化和芳烃受体的作用
- 批准号:
10540334 - 财政年份:2019
- 资助金额:
$ 33.87万 - 项目类别:
The protective role of the AhR Repressor in breast cancer development
AhR 阻遏物在乳腺癌发展中的保护作用
- 批准号:
9918372 - 财政年份:2019
- 资助金额:
$ 33.87万 - 项目类别:
Importance of AhR for the cellular function and communication of dendritic cells
AhR 对树突状细胞的细胞功能和通讯的重要性
- 批准号:
8239472 - 财政年份:2012
- 资助金额:
$ 33.87万 - 项目类别:
Importance of AhR for the cellular function and communication of dendritic cells
AhR 对树突状细胞的细胞功能和通讯的重要性
- 批准号:
8667446 - 财政年份:2012
- 资助金额:
$ 33.87万 - 项目类别:
Importance of AhR for the cellular function and communication of dendritic cells
AhR 对树突状细胞的细胞功能和通讯的重要性
- 批准号:
8518324 - 财政年份:2012
- 资助金额:
$ 33.87万 - 项目类别:
Role of Aryl hydrocarbon receptor (AhR) and RelB during the initiation of dendrit
芳烃受体 (AhR) 和 RelB 在树突形成过程中的作用
- 批准号:
7895003 - 财政年份:2009
- 资助金额:
$ 33.87万 - 项目类别:
Role of Aryl hydrocarbon receptor (AhR) and RelB during the initiation of dendrit
芳烃受体 (AhR) 和 RelB 在树突形成过程中的作用
- 批准号:
7740312 - 财政年份:2009
- 资助金额:
$ 33.87万 - 项目类别:
相似国自然基金
光调控机体获得性免疫应答治疗肿瘤的效应和机制探讨
- 批准号:62005085
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
具有温度/pH双重响应和甘露糖受体靶向功能的微凝胶疫苗
- 批准号:51903233
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
基于DNA自组装技术的人工抗原呈递细胞设计构建及其免疫功能评价
- 批准号:21907073
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
高同型半胱氨酸血症放大高脂引起动脉粥样硬化早期发病--管周脂肪的抗原呈递作用
- 批准号:91439206
- 批准年份:2014
- 资助金额:270.0 万元
- 项目类别:重大研究计划
内淋巴囊上皮细胞在内耳免疫调控作用中的分子机制研究
- 批准号:81371084
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
Tri-Signal Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的三信号人工抗原呈递细胞
- 批准号:
10751133 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的微流控精密工程人工抗原呈递细胞
- 批准号:
10696138 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10663066 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10537159 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
Analysis of the function of antigen-presenting cells present in the stroma of colorectal cancer and the intracellular microbiome
结直肠癌基质中抗原呈递细胞和细胞内微生物组的功能分析
- 批准号:
21K08723 - 财政年份:2021
- 资助金额:
$ 33.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)